




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Advanced Lipid Testing</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=1049cd29-7519-4ec9-9b2f-a012cd071676</link>
        <description>Clinical Topic Feed: Advanced Lipid Testing</description>
        <language>en</language>

        

                <item>
                    <title>Lp(a) HORIZON: Pelacarsen vs. Placebo in Patients With High Lp(a)</title>
<link>/Latest-in-Cardiology/Articles/2026/11/06/14/37/sat-10am-lpa-aha-2026</link>                    <description>Pelacarsen did not result in a lower risk of major adverse cardiovascular events compared with placebo in patients with preexisting cardiovascular disease and high lipoprotein(a) (Lp(a)) over a median follow-up period of approximately five years, based on findings from the Lp(a) HORIZON trial presented at AHA 2026 and simultaneously published in NEJM.</description>
                    <pubdate>1794063960000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>New Insights Across CV Medicine Take Center Stage in JACC Journals at AHA 2026</title>
<link>/Latest-in-Cardiology/Articles/2026/11/06/14/37/New-Insights-Across-CV-Medicine-Take-Center-Stage-in-JACC-Journals-aha-2026</link>                    <description>Several studies from AHA 2026 exploring topics like sex differences in heart failure (HF), emerging cardio-oncology biomarkers and translational models for hypertrophic cardiomyopathy (HCM), are among the simultaneous publications included in JACC Journals. Highlights from key studies published in JACC: Advances, JACC: Basic to Translational Science and JACC: Heart Failure are below.</description>
                    <pubdate>1793998140000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC in a Flash | Persistent Excess CV Mortality in Black Americans; TAVR at 10 Years; More</title>
<link>/Latest-in-Cardiology/Articles/2026/09/01/01/JACC-in-a-Flash</link>                    <description>Featured topics and Editors&#39; Picks from all of ACC&#39;s JACC Journals.</description>
                    <pubdate>1788264600000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Clopidogrel vs. Aspirin Following PCI</title>
<link>/Latest-in-Cardiology/Articles/2026/07/01/12/47/eagles-eye-view-01jul2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle looks at how genotype independently predicts heart failure outcomes in patients with hypertrophic cardiomyopathy (HCM).</description>
                    <pubdate>1782910140000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Combined LDL-C, Lp(a) and hsCRP Assessment Identifies Long-Term Risk of ASCVD</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/06/23/13/25/Combined-LDL-C-Lpa-and-hsCRP-Assessment</link>                    <description>Combined assessment of LDL-C, Lp(a) and hsCRP reflected independent pathways for identifying individuals of varied ethnicities at greater long-term risk of atherosclerotic cardiovascular disease (ASCVD), according to an analysis of the HELIUS cohort published June 24 in JACC.</description>
                    <pubdate>1782413280000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC Spotlight Issue Provides Expert Insight on 2026 Dyslipidemia Guideline</title>
<link>/Latest-in-Cardiology/Articles/2026/05/19/15/49/JACC-Spotlight-Issue-2026-Dyslipidemia-Guideline</link>                    <description>A special JACC Spotlight Issue supporting the recently published 2026 ACC/AHA Guideline on the Management of Dyslipidemia, offers commentaries that provide a comprehensive overview of the new guideline recommendations and expert insights into understanding the science behind the recommendations...</description>
                    <pubdate>1779206040000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ODYSSEY OUTCOMES Analysis: Elevated OxPL-apoB Levels Predict MACE But Alirocumab Attenuates Risk</title>
<link>/Latest-in-Cardiology/Journal-Scans/2025/12/09/16/51/ODYSSEY-OUTCOMES</link>                    <description>Although elevated oxidized phospholipids on apolipoprotein B-100 (OxPL-apoB) levels predicted major adverse cardiovascular events (MACE) in patients with a recent acute coronary syndrome (ACS) receiving optimized statin treatment, alirocumab significantly attenuated the risk.</description>
                    <pubdate>1765375740000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Feature | Lipoprotein(a): An Independent Risk Factor For CV Disease</title>
<link>/Latest-in-Cardiology/Articles/2025/12/01/01/Feature-Lipoprotein-a</link>                    <description>Lipoprotein(a) [Lp(a)] has evolved from a biochemical curiosity to a central player in cardiovascular risk assessment, with elevated levels affecting approximately 1.5 billion people worldwide as an independent and causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve disease.</description>
                    <pubdate>1764594900000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC in a Flash | Growing Evidence Surrounding Lp(a), Trends in CVD Mortality in US, More</title>
<link>/Latest-in-Cardiology/Articles/2025/08/01/01/JACC-in-a-Flash</link>                    <description>Featured topics and Editors&#39; Picks from all of ACC&#39;s JACC Journals.</description>
                    <pubdate>1754050200000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Predicting Long-Term Risk of CVD in US Adults With the PREVENT Equations</title>
<link>/Latest-in-Cardiology/Journal-Scans/2025/06/11/14/30/Predicting-Long-Term-Risk-of-CVD</link>                    <description>Most adults in the U.S. have elevated long-term risks of cardiovascular disease based on findings using the PREVENT risk equations, published June 9 in JACC.</description>
                    <pubdate>1749668700000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>